Einat Brill Almon
2017
In 2017, Einat Brill Almon earned a total compensation of $519.2K as Senior Vice President, Product Development at Protalix BioTherapeutics, a 27% increase compared to previous year.
Compensation breakdown
| Bonus | $157,508 |
|---|---|
| Option Awards | $37,686 |
| Salary | $249,243 |
| Other | $74,798 |
| Total | $519,235 |
Almon received $249.2K in salary, accounting for 48% of the total pay in 2017.
Almon also received $157.5K in bonus, $37.7K in option awards and $74.8K in other compensation.
Rankings
In 2017, Einat Brill Almon's compensation ranked 11,710th out of 14,666 executives tracked by ExecPay. In other words, Almon earned more than 20.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,710 out of 14,666 | 20th |
Division Manufacturing | 4,607 out of 5,772 | 20th |
Major group Chemicals And Allied Products | 1,685 out of 2,075 | 19th |
Industry group Drugs | 1,395 out of 1,731 | 19th |
Industry Biological Products, Except Diagnostic Substances | 247 out of 313 | 21st |
Source: SEC filing on March 6, 2018.
Almon's colleagues
We found four more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2017.
2017
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2017
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2017
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2017
Tzvi Palash
Protalix BioTherapeutics